William N. Rayner

Scottish Equity Partners LLP (Scottish Equity Partners) is a private equity firm founded in 1991 by Gary de Vinchelez Le Sueur and Andrew S. Paterson. The firm is headquartered in London, the United Kingdom.

BBC Studios Distribution Ltd. engages in investing, commercializing, and showcasing content from the British Broadcasting Corporation. It focuses on the acquisition, development, exploitation, licensing, and sale of intellectual properties. The firm’s activities include content sales and co-productions, consumer products, BBC.com, and BBC Worldwide productions. The company was founded in 1979 and is headquartered in London, the United Kingdom.

Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK.

Downing Ventures (Downing Ventures) is an independent venture capital firm founded in 1986. The firm is headquartered in London.

Micromass UK Ltd. develops, manufactures and distributes analytical instruments. The firm manufactures a line of mass spectrometry products. It offers various platforms for drug discovery applications based on its technology. Mircomass is a wholly owned subsidiary of Waters Corp. The company was founded in 1996 and is headquartered in Manchester, UK.

Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.

GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

IDEA AG develops pain therapeutics and biopharmaceutical drugs. The firm develops and commercializes non-invasive therapeutic drugs and the targeted pain therapeutics for arthritic and osteoporosis-related inflammation, chronic pain and diseases. Its technology platform is based on proprietary carriers applied on skin and engineered to diminish side effects and increase drug potency. The company founded by Gregor Cevc in 1993 and is headquartered in Munich, Germany.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom.

Part of Revvity, Inc., PerkinElmer Informatics, Inc. is a company that provides industry-leading chemistry applications and software. The company is based in Cambridge, MA. The company's Informatics solutions empower scientists and researchers to gain critical insights from data analytics, accelerating informed decisions. The company was founded in 1986 by Michael C. Rubenstein and Stewart D. Rubenstein. PerkinElmer Informatics was acquired by Revvity, Inc. from Health Evolution Management Co. LLC on March 24, 2011.

Minnesota Steel Industries LLC manufactures steel. It incorporated the commercially available technology in mining, concentrating, pellet plant, DRI and electric arc steelmaking on a single site, making it one of the lowest cost steel producers in the world. The company is headquartered in St. Paul, MN.

Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom.

Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London.

RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom.

Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937.

Nexeon Ltd. develops novel battery technology and silicon anodes. It is a battery materials and licensing company developing silicon anodes for the next generation of lithium-ion battery. The firm's silicon anodes enable significantly greater Li-ion battery capacity to be achieved, providing lighter batteries with more power and longer lifetime between charges. The company was founded by Mino Green and Paul David Atherton on February 22, 2006 and is headquartered in Abingdon, the United Kingdom.

Touchstone Innovations Businesses LLP commercializes academic research and technology businesses. The company was founded on December 19, 2007 and is headquartered in London, the United Kingdom.

EMcision Ltd. develops medical devices. Its products include Habib EndoHPB, Endoblate, VesCoag, VesOpen, Percutaneous HPB, and EUS RFA. The firm's products are used for laparoscopic, vascular and endoscopic surgeries. It serves in the area of research and development and commercial sectors. The company was founded by Nagy Habib on June 16, 1999 and is headquartered in London, the United Kingdom.

Rolls-Royce Motor Cars New England imports and wholesales automobiles, parts and accessories. It offers finance center, used and pre-owned specials, part specials, and service centers. The company is headquartered in Wayland, MA.

Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom.

Part of Otsuka Holdings Co., Ltd., Veryan Holdings Ltd. is a holding British company that provides research and development services for clinical trials of novel vascular devices. The company is based in Oxford, UK and was founded in 2007.

The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin.

Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom.

Zihipp Ltd. develops peptide hormones for the treatment of diabetes and obesity.

Aqdot Ltd. develops novel fabrication technology for smart capsules. Its technology simplifies the encapsulation process by utilizing the novel one-step, "shrink-wrap" approach based on a combination of emulsion technology and supramolecular chemistry. The company was founded by Jing Zhang, Chris Abell, Oren Scherman, and Roger Coulston in 2012 and is headquartered in Cambridge, the United Kingdom.

Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom.

O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom.

Climate-Kic is a community-based organization that aims to accelerate the transition to a zero-carbon future.

Inhealth Ventures Ltd (Inhealth Ventures) is a venture capital firm, a subsidiary of InHealth Group Ltd. founded in 2016 by Benedict Evans. The firm is headquartered in London, the United Kingdom.

British Patient Capital Ltd (British Patient Capital) is a venture capital firm subsidiary of British Business Bank PLC founded in 2018. The firm is headquartered in Sheffield, United Kingdom.

Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom.